title: Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse.
authors.affiliation: AO Sant'Andrea, UOS Diagnosi e Cura delle Discrasie Plasmacellulari e delle Amiloidosi, Rome, Italy
authors.forename: A
authors.initials: A
authors.lastname: Moscetti
authors.forename: F
authors.initials: F
authors.lastname: Saltarelli
authors.forename: M P
authors.initials: MP
authors.lastname: Bianchi
authors.forename: B
authors.initials: B
authors.lastname: Monarca
authors.forename: L
authors.initials: L
authors.lastname: De Biase
authors.forename: R
authors.initials: R
authors.lastname: Porrini
authors.forename: G
authors.initials: G
authors.lastname: Antolino
authors.forename: G
authors.initials: G
authors.lastname: La Verde
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D001897:Boronic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004452:Echocardiography; D005260:Female; D006801:Humans; D007147:Immunoglobulin Light Chains; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence
chemical_list: D001897:Boronic Acids; D007147:Immunoglobulin Light Chains; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone